BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 27880726)

  • 1. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.
    Youn DH; Park J; Kim HL; Jung Y; Kang J; Jeong MY; Sethi G; Seok Ahn K; Um JY
    Oncotarget; 2017 Feb; 8(6):9500-9512. PubMed ID: 27880726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model.
    Lee G; Shin J; Choi H; Jo A; Pan S; Bae D; Lee Y; Choi C
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28953224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase.
    Choi HM; Jung Y; Park J; Kim HL; Youn DH; Kang J; Jeong MY; Lee JH; Yang WM; Lee SG; Ahn KS; Um JY
    Sci Rep; 2016 Aug; 6():31906. PubMed ID: 27549514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5α- reductase type 2 and induced cell apoptosis.
    Karunasagara S; Hong GL; Jung DY; Kim KH; Cho K; Jung JY
    PLoS One; 2020; 15(8):e0236879. PubMed ID: 32790676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quisqualis indica Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis.
    Ub Wijerathne C; Park HS; Jeong HY; Song JW; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Yeon SH; Kwun HJ
    Biol Pharm Bull; 2017 Dec; 40(12):2125-2133. PubMed ID: 28943529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoralea corylifolia L. extract ameliorates benign prostatic hyperplasia by regulating prostate cell proliferation and apoptosis.
    Kim HJ; Jin BR; An HJ
    J Ethnopharmacol; 2021 Jun; 273():113844. PubMed ID: 33485982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase
    Youn DH; Park J; Kim HL; Jung Y; Kang J; Lim S; Song G; Kwak HJ; Um JY
    Front Pharmacol; 2018; 9():773. PubMed ID: 30061836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pao Pereira Extract Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by inhibiting 5α-Reductase.
    Liu J; Fang T; Li M; Song Y; Li J; Xue Z; Li J; Bu D; Liu W; Zeng Q; Zhang Y; Yun S; Huang R; Yan J
    Sci Rep; 2019 Dec; 9(1):19703. PubMed ID: 31873149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uvaria rufa Blume attenuates benign prostatic hyperplasia via inhibiting 5α-reductase and enhancing antioxidant status.
    Buncharoen W; Saenphet K; Saenphet S; Thitaram C
    J Ethnopharmacol; 2016 Dec; 194():483-494. PubMed ID: 27732901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asteris Radix et Rhizoma suppresses testosterone-induced benign prostatic hyperplasia in rats by regulating apoptosis and inflammation.
    Rho J; Seo CS; Park HS; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
    J Ethnopharmacol; 2020 Jun; 255():112779. PubMed ID: 32209388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Lespedeza Cuneata aqueous extract on testosterone-induced prostatic hyperplasia.
    Park BK; Kim CW; Kwon JE; Negi M; Koo YT; Lee SH; Baek DH; Noh YH; Kang SC
    Pharm Biol; 2019 Dec; 57(1):90-98. PubMed ID: 30724641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways.
    Elbaz EM; Amin HAA; Kamel AS; Ibrahim SM; Helmy HS
    Inflammopharmacology; 2020 Oct; 28(5):1407-1420. PubMed ID: 32785828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat-Killed and Live
    Choi YJ; Fan M; Tang Y; Iwasa M; Han KI; Lee H; Hwang JY; Lee B; Kim EK
    J Microbiol Biotechnol; 2021 Aug; 31(8):1134-1143. PubMed ID: 34226410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of
    Choi YJ; Kim EK; Fan M; Tang Y; Hwang YJ; Sung SH
    Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31591335
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats.
    Jeon WY; Kim OS; Seo CS; Jin SE; Kim JA; Shin HK; Kim YU; Lee MY
    BMC Complement Altern Med; 2017 Aug; 17(1):384. PubMed ID: 28774334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.
    Kumar R; Verma V; Sarswat A; Maikhuri JP; Jain A; Jain RK; Sharma VL; Dalela D; Gupta G
    Invest New Drugs; 2012 Apr; 30(2):582-93. PubMed ID: 21181231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells.
    Jung Y; Park J; Kim HL; Youn DH; Kang J; Lim S; Jeong MY; Sethi G; Park SJ; Ahn KS; Um JY
    Oncotarget; 2017 Oct; 8(50):87194-87208. PubMed ID: 29152074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
    Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
    J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis.
    Jin BR; An HJ
    Aging (Albany NY); 2020 Feb; 12(3):2142-2155. PubMed ID: 32018227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
    Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
    Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.